The cajanine derivative LJ101019C regulates the proliferation and enhances the activity of NK cells via Kv1.3 channel-driven activation of the AKT/mTOR pathway. 
Natural killer (NK) cells play important roles in immune responses and have been wildly used in immunotherapy.  Nevertheless, some limitations remain.  It is urgent to explore novel and safe strategies to enhance NK cell activity.  The aim of this study was to investigate the immuno-stimulatory effects and to reveal the molecular mechanism of LJ101019C, a derivative of a natural small-molecule compounds cajanine, on NK cells.  Cell proliferation was examined by CCK8 assay, then we used the cytotoxicity detection kit to detect the cytotoxicity of NK cells.  The change of cell cycle, intracellular reactive oxygen species (ROS) level and mitochondrial mass were evaluated by FACS and Operetta high-content image analysis, respectively.  Furthermore, the IFN-γ secretion of NK cells were measured by ELISA.  The Kv1.3 protein expression and function were detected by western blot and patch-clamp technique, respectively.  The role of Kv1.3 in AKT/mTOR pathway activation was determined by western blot.  The results showed that LJ101019C at relatively low concentrations (0.05-0.1 µM) significantly increased the proliferation of NK cells.  And 1 µM LJ101019C could elevate the proportion of NK cells in the S-phase of the cell cycle (*p < 0.1).  Furthermore, the cytotoxic effects of NK cells targeting MIA PaCa-2 cells were significantly enhanced by 0.1 and 1 µM LJ101019C, and were associated with the enhanced secretion of IFN-γ by NK cells (*p < 0.1; **p < 0.05).  0.1 and 1 µM LJ101019C increased intracellular levels of ROS (**p < 0.05), and 0.1 µM LJ101019C elevated mitochondrial mass (*p < 0.1).  Electrophysiological recordings indicated that LJ101019C led to a remarkably increase the Kv1.3 current density.  Moreover, western blot results indicated that LJ101019C elevated Kv1.3 protein expression and activated AKT/mTOR signaling via increasing the expression of Kv1.3 in NK cells.  LJ101019C increases the proliferation and the cytotoxicity of NK cells at relatively low concentrations.  The mechanism is the activation of AKT/mTOR signaling pathway driven by up-regulation of Kv1.3 in NK cells.  These suggest LJ101019C is a promising candidate for improving the efficacy of NK cell-based immunotherapies.